Register and share your invite link to earn from video plays and referrals.

Search results for ZeroLeprosy
ZeroLeprosy community
One keyword maps to one global community path.
Create community
People
Not Found
Tweets including ZeroLeprosy
From lived experience to global advocacy. Amar now chairs the Prioritising People pillar at GPZL—ensuring voices of persons affected by leprosy shape decisions that matter. #ZeroLeprosy# #EndStigma# #NothingAboutUsWithoutUs# #GlobalHealth# #Inclusion#
Show more
This #WorldLeprosyAwarenessMonth# 2026, GPZL calls for early diagnosis, inclusive care, and an end to discrimination. Together, we can achieve #ZeroLeprosy# — zero disease, zero disability, zero stigma. #WorldLeprosyDay2026# #HansenDisease# #EndStigma# #LeaveNoOneBehind#
Show more
The Zero Leprosy Toolkit is a free, field-tested set of best practices supporting countries to end leprosy, prevent disabilities, and eliminate stigma. Learn more: #ZeroLeprosy# #EndLeprosy# #NTDs# #GlobalHealth# #endstigma#
Show more
We are pleased to launch the Zero Leprosy Best Practices Toolkit! A comprehensive resource to strengthen prevention, treatment, & community engagement worldwide. Available in 5 languages (Bahasa, FR, HI, PT, ES). 👇 #ZeroLeprosy# #PublicHealth# #document#
Show more
Small org led by persons affected by leprosy? GPZL's new 2026 Capacity-Building Pilot offers tailored support in leadership, digital skills, and advocacy! 🗓️ Deadline: May 20, 2026 ✉️ Contact: admin@zeroleprosy.org Read More #ZeroLeprosy#
Show more
Advancing towards our goal of zero disease, zero disability, and zero stigma: Our Q4 2025 Update is Here! Together, we are rooted in partnership and driven by change. Read the full newsletter here: #ZeroLeprosy# #GlobalHealth# #PublicHealth# #EndStigma#
Show more
The Global Partnership for Zero Leprosy (GPZL) is launching a global survey to map the “last-mile” challenges and successes in delivering multidrug therapy (MDT) to every person who needs it. Scan the QR code or click the link below to take the survey.
Show more